Cited by 115Genetic Neurodegenerative DiseasesBiochemical Acid Research StudiesParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Lipoic acid improves survival in transgenic mouse models of Huntington's disease

Abstract

There is substantial evidence implicating excitotoxicity and oxidative damage in the pathogenesis of Huntington's disease (HD). We therefore examined whether the antioxidants 2-sulpho-tert-phenyibutyinitrone (S-PBN) and alpha-lipoic acid could exert neuroprotective effects in transgenic mouse models of HD. S-PBN showed no effects on either weight loss or survival in the R6/2 transgenic HD mice. alpha-Lipoic acid produced significant increases in survival in both R6/2 and N171-82Q transgenic mouse models of HD. These findings suggest that alpha-lipoic acid might have beneficial effects in HD patients.

Overview

Integrity signals

Registry

Crossref · 10.1097/00001756-200110290-00044

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 23 references

Research works printed but not linked: 1

  1. Arivazhagan, 2001, J Nutr Sci, 12, 2

Cited by

Sorted by citations

See all 115

Metadata

Authors
Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., & Beal, M. F.
Affiliations
Boston University (US)
Venue
Neuroreport
Published
2001-10
Volume
12
Issue
15
Pages
3371-3373
ISSN
0959-4965 (ISSN-L)
OpenAlex
W2022851867
Cited by
115
References
23
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 7
FWCI
3.44
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroreport (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (AG 12992, AG 14390, P01AG012992)
  • National Institute of Neurological Disorders and Stroke (NS38180)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
Huntington's disease, alpha-lipoic acid, antioxidants, neuroprotection, survival, R6/2 transgenic mice, excitotoxicity, oxidative damage
MeSH terms
Animals, Antioxidants, Benzenesulfonates, Body Weight, Brain, Disease Models, Animal, Food, Formulated, Huntington Disease, Thioctic Acid, Male, Mice, Transgenic, Survival, Treatment Outcome, Oxidative Stress, Neuroprotective Agents, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review